132 related articles for article (PubMed ID: 6339880)
1. [3H]ethylketocyclazocine binding to NCB-20 hybrid neurotumor cells.
West RE; McLawhon RW; Dawson G; Miller RJ
Mol Pharmacol; 1983 Mar; 23(2):486-92. PubMed ID: 6339880
[TBL] [Abstract][Full Text] [Related]
2. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
McLawhon RW; West RE; Miller RJ; Dawson G
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
[TBL] [Abstract][Full Text] [Related]
3. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
Kushner L; Zukin SR; Zukin RS
Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
[TBL] [Abstract][Full Text] [Related]
4. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
Garzón J; Sánchez-Blázquez P; Lee NM
J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
[TBL] [Abstract][Full Text] [Related]
5. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
6. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
7. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
8. Characterization of opioid binding sites in murine neuroblastoma.
Zagon IS; Goodman SR; McLaughlin PJ
Brain Res; 1988 May; 449(1-2):80-8. PubMed ID: 2899449
[TBL] [Abstract][Full Text] [Related]
9. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
10. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
Nock B; Rajpara A; O'Connor LH; Cicero TJ
Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
[TBL] [Abstract][Full Text] [Related]
11. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
Itzhak Y; Hiller JM; Simon EJ
Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
[TBL] [Abstract][Full Text] [Related]
12. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
[TBL] [Abstract][Full Text] [Related]
13. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
Ishizuka Y; Oka T
Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor.
Wu XZ; Bell JA; Spivak CE; London ED; Su TP
J Pharmacol Exp Ther; 1991 Apr; 257(1):351-9. PubMed ID: 1850471
[TBL] [Abstract][Full Text] [Related]
15. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
[TBL] [Abstract][Full Text] [Related]
17. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
[TBL] [Abstract][Full Text] [Related]
18. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
Tam SW
Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
Nishimura SL; Recht LD; Pasternak GW
Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
[TBL] [Abstract][Full Text] [Related]
20. Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors.
Hiller JM; Simon EJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):516-9. PubMed ID: 6249910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
